FUSION BIOVENTURE
LIVE

Serial Number

97276885

Owner

Fosun Pharma USA Inc.

Attorney

Perry Gattegno

Filing Date

Feb 21, 2022

Add to watchlist:

No watchlists yet
View on USPTO

FUSION BIOVENTURE Trademark

Serial Number: 97276885 • Registration: 7011432

FUSION BIOVENTURE is a trademark filed by Fosun Pharma USA Inc. on February 21, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Fosun Pharma USA Inc. (13 trademarks)

104 Carnegie Center Drive, Suite 204
Princeton, NJ 08540

Entity Type: 03

Trademark Details

Filing Date

February 21, 2022

Registration Date

March 28, 2023

Published for Opposition

January 10, 2023

Goods & Services

Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies

Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Pharmaceutical research and development; Scientific research and development; Vaccine research and development

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 28, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 10, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 10, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 21, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2022 CNSA
ASSIGNED TO EXAMINER
Dec 5, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2022 NWOS
NEW APPLICATION ENTERED
Feb 24, 2022 NWAP